Xlife Sciences AG (XLS) — Cash Flow-to-Debt Ratio
Xlife Sciences AG (XLS) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2025, meaning its operating cash flow of CHF-803.62K could theoretically repay 0% of its total liabilities (CHF232.84 Million) in one year. See XLS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xlife Sciences AG Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Xlife Sciences AG across 6 annual periods. Also explore Xlife Sciences AG annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Xlife Sciences AG (2019–2024)
Year-by-year debt coverage analysis for Xlife Sciences AG. For market capitalisation and broader financial context, see market value of Xlife Sciences AG.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | CHF-421.51K | CHF235.11 Million | ▼ -354.5% |
| 2023 | 0.00x | CHF171.78K | CHF243.82 Million | ▲ +103.9% |
| 2022 | -0.02x | CHF-4.61 Million | CHF255.00 Million | ▼ -12.3% |
| 2021 | -0.02x | CHF-4.32 Million | CHF268.83 Million | ▼ -122.4% |
| 2020 | -0.01x | CHF-401.55K | CHF55.51 Million | ▼ -2.9% |
| 2019 | -0.01x | CHF-398.24K | CHF56.64 Million | — |